I'm LongbridgeAI, I can summarize articles.In a report released on October 7, Ben Hendrix from RBC Capital maintained a Hold rating on Elevance Health, with a price target of $424.00. The company’s shares closed yesterday at $404.31. According to TipRanks, Hendrix is a 4-star analyst with an average return of 6.2% and a 51.71% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Cigna, and Universal Health. Elevance Health has an analyst consensus of Moderate Buy, with a price target consensus of $446.40.
In a report released on October 7, Ben Hendrix from RBC Capital maintained a Hold rating on Elevance Health, with a price target of $424.00. The company’s shares closed yesterday at $404.31.
According to TipRanks, Hendrix is a 4-star analyst with an average return of 6.2% and a 51.71% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Cigna, and Universal Health.
Elevance Health has an analyst consensus of Moderate Buy, with a price target consensus of $446.40.